Japan Tobacco Is First Customer for Gene Logic's Database | GenomeWeb

COLUMBIA, Md.--Gene Logic here has announced that it will collaborate with Japan Tobacco to uncover drug targets and leads in kidney disease. Gene Logic will utilize its proprietary Accelerated Drug Discovery platform in the effort. Japan Tobacco will also be the first subscriber to Gene Logic's Gene Express Normal database of quantitative gene expression profiles in a variety of normal tissues of human, rat, and mouse origin. The deal also gives Japan Tobacco the option of accessing Gene Logic's Flow-thru Gene Chip technology for high-throughput screening.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.